Is Early Post Operative Chemotherapy a feasible alternative to Hyperthermic Intra Peritoneal Chemotherapy ?
Not Applicable
- Conditions
- Health Condition 1: C569- Malignant neoplasm of unspecifiedovaryHealth Condition 2: C569- Malignant neoplasm of unspecifiedovary
- Registration Number
- CTRI/2022/03/041388
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 18year to 70 years.
Epithelial ovarian, fallopian tube or primary peritoneal cancer histology
Stage 3 and stage 4 disease as per ovarian cancer staging AJCC-TNM 8th edition.
Received Neoadjuvant chemotherapy
Performance status â?? ECOG :1 or optimized ECOG: 2.
Patients willing for regular follow-up.
Exclusion Criteria
Patients received chemotherapy in another hospital before visiting the centre.
Second primary cancer.
Poor general condition (unlikely to tolerate or complete the proposed treatment course).
Patients unwilling to give consent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study perioperative morbidity and mortality, side effect and toxicity profile in advanced epithelial ovarian, fallopian, primary peritoneal cancer undergoing Cytoreductive surgery with Early Postoperative Intraperitoneal Chemotherapy or Hyperthermic Intra Peritoneal Chemotherapy.Timepoint: 2 months post surgery
- Secondary Outcome Measures
Name Time Method To study the quality of life in advanced epithelial ovarian, fallopian, primary peritoneal cancer undergoing interval cytoreduction with Early Postoperative Intraperitoneal Chemotherapy or Hyperthermic Intra Peritoneal ChemotherapyTimepoint: 2 months post op